A humanized bone-forming ectopic xenotransplantation model was set up by using hMSCs treated with BMP-2, and applied as pseudo-orthotopic approach to grow CI-competent (143B+/+) and CI-deficient (143B−/−) osteosarcoma cells in vivo (Figure 1a). This evidence concerns the gene BMP2 and osteosarcoma.